XXII Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Stats
Today's Volume	144 360
Average Volume	1.54M
Market Cap	10.10M
EPS	$0 ( 2024-03-28 )
Next earnings date	( $-0.550 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0300
ATR14	$0.00500 (0.30%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-06	Otto Daniel A	Sell	0	Common Stock
2024-04-06	Staffeldt Jonathan	Sell	0	Common Stock
2024-01-05	Arno Andrew	Buy	100 000	Common Stock
2024-01-04	Firestone Lawrence	Buy	100 000	Common Stock
2023-12-01	Firestone Lawrence	Buy	0

INSIDER POWER
66.73
Last 91 transactions
Buy: 8 846 121 \| Sell: 4 190 953

Volume Correlation

Long: -0.22 (neutral)

Short: 0.23 (neutral)

Signal:(41.579) Neutral

22nd Century Group Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

22nd Century Group Inc Correlation - Currency/Commodity

-0.20
( neutral )

0.12
( neutral )

0.00
( neutral )

0.34
( neutral )

22nd Century Group Inc Financials

Annual	2023
Revenue:	$32.20M
Gross Profit:	$-9.34M (-29.00 %)
EPS:	$-108.75

FY	2023
Revenue:	$32.20M
Gross Profit:	$-9.34M (-29.00 %)
EPS:	$-108.75

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

FY	2022
Revenue:	$62.11M
Gross Profit:	$1.17M (1.89 %)
EPS:	$-1 116.40

Financial Reports:

No articles found.

22nd Century Group Inc

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Realtime updates for 22nd Century Group Inc [XXII]

Upcoming Earnings Alert